These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 14199705

  • 1. TREATMENT OF PERIPHERAL VASCULAR OCCLUSION BY STREPTOKINASE PERFUSION.
    MCNICOL GP, DOUGLAS AS.
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:23-9. PubMed ID: 14199705
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.
    HAWKEY C, HOWELL M.
    J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462
    [Abstract] [Full Text] [Related]

  • 4. EXPERIENCE WITH STREPTOKINASE AS A THROMBOLYTIC AGENT.
    WINCKELMANN G, HIEMEYER V.
    Scand J Clin Lab Invest; 1964 May; 16():SUPPL 79:7-14. PubMed ID: 14199708
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ON THE PLASMINOGEN ACTIVATOR FORMING CAPACITY OF HUMAN PLASMA GLOBULINS REACTING WITH STREPTOKINASE.
    AUERSWALD W, DOLESCHEL W.
    Med Exp Int J Exp Med; 1964 May; 10():179-84. PubMed ID: 14129855
    [No Abstract] [Full Text] [Related]

  • 8. THE INHIBITORY EFFECT OF LARGE CONCENTRATIONS OF STREPTOKINASE AS RELATED TO PROTEOLYTIC ACTIVITY AND PROACTIVATOR FUNCTION OF HUMAN EUGLOBULIN.
    HELLE I.
    Scand J Haematol; 1964 May; 1():240-56. PubMed ID: 14214904
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. INFLUENCE OF FIBRINOGEN DEGRADATION PRODUCTS (FDP) ON PLATELET AGGREGATION, ADHESIVENESS AND VISCOUS METAMORPHOSIS.
    KOWALSKI E, KOPEC M, WEGRZYNOWICZ Z.
    Thromb Diath Haemorrh; 1964 Jan 01; 10():406-23. PubMed ID: 14113380
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E, SCHMUTZLER R, DUCKERT F.
    Thromb Diath Haemorrh; 1963 Nov 01; 10():106-19. PubMed ID: 14081273
    [No Abstract] [Full Text] [Related]

  • 15. ON THE COMBINED ADMINISTRATION OF STREPTOKINASE AND PANCREATIC TRYPSIN INHIBITOR.
    VERSTRAETE M, VERMYLEN J, VERMYLEN C, DEVREKER RA.
    Thromb Diath Haemorrh; 1964 Dec 31; 12():391-5. PubMed ID: 14254698
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. QUANTITATIVE ESTIMATION OF UROKINASE AND BACTERIAL PLASMINOGEN ACTIVATORS USING A FIBRIN SUBSTRATE FORMED FROM PLASMINOGEN-FREE FIBRINOGEN.
    ANDERSON AJ.
    Biochim Biophys Acta; 1963 Aug 13; 74():554-7. PubMed ID: 14071603
    [No Abstract] [Full Text] [Related]

  • 19. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH, MCNICOL GP, DOUGLAS AS, MELANDER B.
    Lancet; 1964 Dec 19; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.